21 
[Executive Secretary's Note: The version of the "Points to Consider in the 
Design and Submission of Human Somatic-Cell Gene Therapy Protocols" resulting 
from this meeting is Attachment IX.] 
Respectfully siimittod. 
Elizabeth 
A. Milewski, Ph.D 
Rapporteur 
LeRoy Wallers, 
Chair 
W 
Ph.D. 
[106] 
